510(k) Report

510(k) · Cleared

Cleared

Mrsaselect

K070361510(k) TraditionalCleared Sep 13, 2007218-day reviewClass II21 CFR 866.1700

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Bio-Rad · JSO Culture Media, Antimicrobial Susceptibility Test, Excluding Mueller Hinton Agar

Cleared on Sep 13, 2007 as substantially equivalent to K042812 (Becton, Dickinson & CO, 2004) after a 218-day review. Its family tree reaches back 2 generations to 1986. 4 later devices descend from it.

Decided
Sep 13, 2007
Review
218 days
Class
Class II
Product code
JSO
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K863821 (1986). 4 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2008: 1 descendant cleared2017: 1 descendant cleared2010: 1 descendant cleared2016: 1 descendant clearedK863821 · Mueller Hinton Agar W/4%Nacl and Oxacillin · Gibco Laboratories Life Technologies, Inc. · 1986 · recalledK042812 · Bblchromagar Mrsa · Becton, Dickinson & CO · 20041990200020102020
Descendants, by generation 1 generation forward: 1 descendant2 generations forward: 2 descendants3 generations forward: 1 descendant K042812 · Bblchromagar Mrsa · Becton, Dickinson & CO · 2004K863821 · Mueller Hinton Agar W/4%Nacl and Oxacillin · Gibco Laboratories Life Technologies, Inc. · 1986 · recalled0
  1. Root · 2 generations backK863821 Mueller Hinton Agar W/4%Nacl and OxacillinGibco Laboratories Life Technologies, Inc. · 1986 · Recalled
  2. 1 generation backK042812 Bblchromagar MrsaBecton, Dickinson & CO · 2004
  3. This deviceK070361 MrsaselectBio-Rad · 2007
  4. Descendant · cites it directly · 3 of its ownK081212 Mrsaselect - Extended IncubationBio-Rad · 2008 · Recalled
  5. Descendant · 2 generations on · 2 of its ownK100589 Mrsa Select - Skin and Soft Tissue Wound SpecimensBio-Rad · 2010
  6. Descendant · 2 generations on · 0 of its ownK171061 MRSASelect IIBio-Rad · 2017 · Recalled
  7. Descendant · 3 generations on · 0 of its ownK151688 chromID MRSAbioMerieux, Inc. · 2016

Most influential descendants

Showing 4 of 4 · See all
  • K081212Mrsaselect - Extended IncubationBio-Rad · 2008 · cites it directly3descendants
  • K100589Mrsa Select - Skin and Soft Tissue Wound SpecimensBio-Rad · 2010 · 2 generations on2descendants
  • K171061MRSASelect IIBio-Rad · 2017 · 2 generations on0descendants
  • K151688chromID MRSAbioMerieux, Inc. · 2016 · 3 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K863821Mueller Hinton Agar W/4%Nacl and OxacillinGibco Laboratories Life Technologies, Inc.19861
−1K042812Bblchromagar MrsaBecton, Dickinson & CO2004—
0 (this device)K070361MrsaselectBio-Rad2007—
+1K081212Mrsaselect - Extended IncubationBio-Rad20081
+2K100589Mrsa Select - Skin and Soft Tissue Wound SpecimensBio-Rad2010—
+2K171061MRSASelect IIBio-Rad20171
+3K151688chromID MRSAbioMerieux, Inc.2016—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200810
201010
201610
201710
FIG. 1 — Lineage of K070361, 1986–2017Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JSO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K042812Bblchromagar Mrsa
Summary page 1
…et Beverly, MA 01915 Substantially Equivalent Device MRSASelect is substantially equivalent to BBL CHROMagar MRSA (510(k) number: K042812) Manufacturer: Becton Dickinson & Company Product:…
Becton, Dickinson & CO2004—

Also cleared against K042812: 3 other devices →

What descends from it? (4)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K081212Mrsaselect - Extended IncubationBio-Rad20083

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 21 years and passes through 3 companies; a new generation was cleared every 18.1 years on median.
  • 1 of the 2 ancestors has a recall of any class.
  • Of its descendants, K081212 (Bio-Rad, 2008) has gone furthest, with 3 descendants of its own.
  • 3 other devices also cite its predicate K042812.

How does its category compare?

All JSO devices

JSO Culture Media, Antimicrobial Susceptibility Test, Excluding Mueller Hinton Agar: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.

FDA decisions per year · JSO

1in 2019

2007: 12008: 22009: 12010: 52011: 22012: 12016: 32017: 22018: 12019: 1
2007high 5 (2010) · low 0 (2013)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JSO

262in 2016

2010: 326 days median2016: 262 days median
2007high 326 (2010) · low 262 (2016)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · JSO

15in 2022

2007: 22009: 42011: 32017: 22020: 12022: 15
2007high 15 (2022) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JSO

513in 2025

2008: 12010: 12011: 12013: 12015: 322016: 172017: 432018: 142019: 92020: 72021: 272022: 82023: 122024: 42025: 513
2007high 513 (2025) · low 0 (2007)2025

MAUDE reports naming product code JSO, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—20
20082—01
20091—40
2010532601
20112—31
20121—00
20130—01
20140—00
20150—032
20163262017
20172—243
20181—014
20191—09
20200—17
20210—027
20220—158
20230—012
20240—04
20250—0513
20260—0—

What is it indicated for?

MRSASelect is a selective and differential chromogenic medium for the qualitative detection of

nasal colonization of methicillin resistant Staphylococcus aureus (MRSA) to aid in the prevention

and control of MRSA infections in healthcare settings. The test can be performed on anterior nares

specimens from patients and healthcare workers to screen for MRSA colonization. MRSASelect is

not intended to diagnose MRSA infection nor to guide or monitor treatment of infection.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K070361: Mrsaselect.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K070361

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026